Advanced company searchLink opens in new window

RQ BIOTECHNOLOGY LIMITED

Company number 13293828

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
06 Sep 2024 MA Memorandum and Articles of Association
25 Jul 2024 AA Full accounts made up to 31 March 2024
05 Jun 2024 PSC07 Cessation of Lifearc as a person with significant control on 8 April 2024
05 Jun 2024 PSC02 Notification of Rq Biotechnology Holdings Limited as a person with significant control on 8 April 2024
09 Apr 2024 TM01 Termination of appointment of Jacques Cholat as a director on 9 April 2024
09 Apr 2024 TM01 Termination of appointment of William Ripley Ballou as a director on 9 April 2024
27 Mar 2024 CS01 Confirmation statement made on 25 March 2024 with updates
06 Nov 2023 SH03 Purchase of own shares.
25 Oct 2023 AA Full accounts made up to 31 March 2023
09 Oct 2023 SH08 Change of share class name or designation
06 Oct 2023 PSC02 Notification of Lifearc as a person with significant control on 5 September 2023
05 Oct 2023 TM01 Termination of appointment of Hugo Rupert Alexander Fry as a director on 4 September 2023
05 Oct 2023 PSC09 Withdrawal of a person with significant control statement on 5 October 2023
30 Jun 2023 CH01 Director's details changed for Mr Hugo Rupert Alexander Fry on 19 April 2023
29 Jun 2023 AD01 Registered office address changed from 7th Floor Lynton House 7-12 Tavistock Square London WC1H 9LT United Kingdom to Scale Space 58 Wood Lane London W12 7RZ on 29 June 2023
31 Mar 2023 AD03 Register(s) moved to registered inspection location Camburgh House 27 New Dover Road Canterbury Kent CT1 3DN
31 Mar 2023 AD02 Register inspection address has been changed to Camburgh House 27 New Dover Road Canterbury Kent CT1 3DN
30 Mar 2023 CS01 Confirmation statement made on 25 March 2023 with updates
27 Jan 2023 SH01 Statement of capital following an allotment of shares on 2 December 2022
  • GBP 1.34
26 Jan 2023 AP01 Appointment of Mr William Ripley Ballou as a director on 1 January 2023
26 Jan 2023 AP01 Appointment of Mr Jacques Cholat as a director on 1 January 2023
26 Jan 2023 SH01 Statement of capital following an allotment of shares on 2 December 2022
  • GBP 1.14
24 Jan 2023 MA Memorandum and Articles of Association
24 Jan 2023 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
  • RES01 ‐ Resolution of adoption of Articles of Association
17 Nov 2022 AA Total exemption full accounts made up to 31 March 2022